CAMBRIDGE, Mass., Aug. 25, 2022 -- Aktis Oncology, a biotechnology company discovering and developing novel classes of targeted alpha radiopharmaceuticals to treat a broad range of solid tumors, today announced...
Arthur Klausner will participate on a panel at the Biotechnology Entrepreneurship Boot Camp program that is associated with the the BIO International Convention in San Diego, CA
News | 06. 17. 2008
